“Global Ophthalmic Equipment market set to grow to $75bn by 2024” says new Visiongain report

03 June 2019
Pharma

Visiongain has published a new pharma report The Ophthalmic Equipment Market Forecast 2019-2029: Vision Care Products, Ophthalmology Surgical Devices, Diagnostic and Monitoring Devices, Consumers, Hospitals, Specialty Clinics and Ambulatory Surgery Centres.

The ophthalmic equipment market is estimated to have reached $51 bn in 2018 and is expected to grow at a CAGR of 7.4% during the forecast period. In 2019, Vision Care Products segment held the biggest market share in the ophthalmic equipment market.

This report profiled the selected companies: Alcon, BAUSCH + LOMB Incorporated, Carl Zeiss Meditec AG, Essilor International S.A., Johnson & Johnson Vision, NIDEK CO., LTD., STAAR Surgical Company, Ziemer Ophthalmic Systems AG and others.

The lead analyst commented that "There is a growing demand for ophthalmic equipment such as vision care products and ophthalmology surgical devices, mainly due to the increasing incidence of myopia across the world. As the myopic population increases globally, it provides opportunity for manufacturers of intraocular lenses to expand their market volume in ophthalmology market. Approval of new technology for correction of myopia would further enhance the opportunity for capitalization.

Rapid rise in the geriatric population across the globe, technological advancements in ophthalmic devices for improving the diagnosis and treatment, increasing adoption of digital devices globally are some of the factors which are expected to drive the growth of ophthalmic equipment market during the forecast period."

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

Read

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever